Menu
Oncology
Hermab
Download Leaflet Listen leaflet
Find here loading...
Eg capsules, pills, syrup, 10mg, etc.
Eurofarma does not sell directly to consumers. The prices presented here are for information purposes only and should be checked directly on the offerors website
{{ sku.name }}
In Stock
Find it now
Product Package Image
Image for illustrative purposes only.
Indication
Indicado para o tratamento de câncer de mama HER2-positivo, ajudando a controlar a progressão da doença e a reduzir o risco de recidiva. Também é utilizado no câncer gástrico HER2-positivo avançado
Active Ingredient
Hermab
Concentration
440mg
Presentation
Embalagem contendo 01 frasco ampola 440 mg pó liofilizado para solução injetável
Practical information
Lyophilized Powder for Solution for Injection
Antineoplastics
Sale under medical prescription
Oncology
Contraindication
O Hermab é contraindicado a pacientes com hipersensibilidade ao medicamento, gestantes e pessoas com insuficiência cardíaca grave. O tratamento exige monitoramento cardíaco regular para minimizar os riscos de cardiotoxicidade.
Conscious Use of Medications Manual
So that you can take better care of yourself and those you love, following a safe and effective treatment, we present the manual on the conscious use of medicines. The publication brings together a series of extremely relevant information, presented in a simple and educational way. Access the manual here
Published in: November 6, 2024 
and updated in: December 2, 2024
Se persistirem os sintomas, o médico deverá ser consultado.
Registration 1.0043.1494.002
Eurofarma
About The Company Areas of Expertise Join Our Staff Media Eurofarma Certifications Warnings Awards and Recognition Visitation Program Where We Operate Programa +Diverso
Products
Generic Drugs Hospital Nonprescription Drugs Oncology Prescription Drugs
Innovation
Biotechnology Eurolab New Business Conduct Clinical Research With Us Research and Development EurON
Sustainability
Sustainable Report Corporate Governance Environment Annual Report Corporate Responsibility Sustainability Vision Balance Sheet
© Eurofarma 2025
Privacy Policy